Immune Signature to Predict Trastuzumab Benefit: Potential and Pitfalls

被引：6
|
作者：
Gavin, Patrick G. [1 ]
Song, Nan [1 ]
Kim, S. Rim [1 ]
Pogue-Geile, Katherine L. [1 ]
Paik, Soonmyung [1 ]
机构：
[1] Natl Surg Adjuvant Breast & Bowel Project NRG Onc, Pittsburgh, PA 15260 USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2015年 / 33卷 / 31期
关键词：
ADJUVANT TRASTUZUMAB; TRIAL;
D O I：
10.1200/JCO.2015.61.9650
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：3671 / +
页数：3
相关论文
共 50 条
  • [41] Identification of a prognostic immune signature for cervical cancer to predict survival and response to immune checkpoint inhibitors
    Yang, Si
    Wu, Ying
    Deng, Yujiao
    Zhou, Linghui
    Yang, Pengtao
    Zheng, Yi
    Zhang, Dai
    Zhai, Zhen
    Li, Na
    Hao, Qian
    Song, Dingli
    Kang, Huafeng
    Dai, Zhijun
    ONCOIMMUNOLOGY, 2019, 8 (12):
  • [42] A serum microRNA signature predicts trastuzumab benefit in HER2-positive metastatic breast cancer patients
    Li, Huiping
    Liu, Jiang
    Chen, Jianing
    Wang, Huiyun
    Yang, Linbin
    Chen, Fei
    Fan, Siting
    Wang, Jing
    Shao, Bin
    Yin, Dong
    Zeng, Musheng
    Li, Mengfeng
    Li, Jun
    Su, Fengxi
    Liu, Qiang
    Yao, Herui
    Su, Shicheng
    Song, Erwei
    NATURE COMMUNICATIONS, 2018, 9
  • [43] A serum microRNA signature predicts trastuzumab benefit in HER2-positive metastatic breast cancer patients
    Huiping Li
    Jiang Liu
    Jianing Chen
    Huiyun Wang
    Linbin Yang
    Fei Chen
    Siting Fan
    Jing Wang
    Bin Shao
    Dong Yin
    Musheng Zeng
    Mengfeng Li
    Jun Li
    Fengxi Su
    Qiang Liu
    Herui Yao
    Shicheng Su
    Erwei Song
    Nature Communications, 9
  • [44] Trastuzumab and lapatinib beyond trastuzumab progression for metastatic breast cancer: strategies and pitfalls
    Brandes, Alba A.
    Franceschi, Enrico
    Tosoni, Alicia
    Degli Esposti, Roberta
    EXPERT REVIEW OF ANTICANCER THERAPY, 2010, 10 (02) : 179 - 184
  • [45] Potential Benefit of Low-Dose Candesartan in Trastuzumab- Induced Cardiotoxic Effects
    Yun, Seongseok
    Khoubyari, Rostam
    Abraham, Ivo
    JAMA ONCOLOGY, 2017, 3 (02) : 279 - 279
  • [46] Immune Effects of Trastuzumab
    Nuti, Marianna
    Bellati, Filippo
    Visconti, Valeria
    Napoletano, Chiara
    Domenici, Lavinia
    Caccetta, Jlenia
    Zizzari, Ilaria Grazia
    Ruscito, Ilary
    Rahimi, Hassan
    Benedetti-Panici, Pierluigi
    Rughetti, Aurelia
    JOURNAL OF CANCER, 2011, 2 : 317 - 323
  • [47] Potential pitfalls of nanotechnology in its applications to medicine: Immune incompatibility of nanodevices
    Shetty, RC
    MEDICAL HYPOTHESES, 2005, 65 (05) : 998 - 999
  • [48] Exploiting human herpesvirus immune evasion for therapeutic gain: potential and pitfalls
    Horst, Danielle
    Ressing, Maaike E.
    Wiertz, Emmanuel J. H. J.
    IMMUNOLOGY AND CELL BIOLOGY, 2011, 89 (03): : 359 - 366
  • [49] An immune-related prognostic signature for thyroid carcinoma to predict survival and response to immune checkpoint inhibitors
    Pu Wu
    Wei Sun
    Hao Zhang
    Cancer Immunology, Immunotherapy, 2022, 71 : 747 - 759
  • [50] Immune-Related lncRNA to Construct Novel Signature and Predict the Immune Landscape of Human Hepatocellular Carcinoma
    Hong, Weifeng
    Li, Liang
    Gu, Yujun
    Qi, Zhenhua
    Qiu, Haibo
    Yang, Xiaosong
    Zeng, Weian
    Ma, Liheng
    Xie, Jingdun
    MOLECULAR THERAPY-NUCLEIC ACIDS, 2020, 22 : 937 - 947
12345